Depression

Practitioners discuss the need to treat patients with major depressive disorder (MDD) to a complete remission vs a decline in symptomology.

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss best practices for monitoring and follow-up with patients with major depressive disorder (MDD) to ensure treatment efficacy and safety.

Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).

Your daily dose of clinical news you may have missed.

Experts discuss how practitioners are viewing major depressive disorder (MDD) as a chronic condition vs an episodic condition.

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss navigating the challenge of a “one size fits all approach” when treating and identifying the specific needs of patients with major depressive disorder (MDD).

The predictive value of loneliness for cardiovascular disease in patients with diabetes was stronger than traditional lifestyle risk factors in large UK Biobank analysis.

The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.

Your daily dose of clinical news you may have missed.

Practitioners discuss the rates of undertreatment in patients suffering from major depressive disorder (MDD).

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, comment on the perception of major depressive disorder (MDD) within the healthcare community and the clinical and practical implications of is this condition.

Primary care clinicians should screen all adults for the 3 mental health conditions to ensure timely referral for appropriate treatment.

A nationally recognized obesity expert discusses mental health in women with obesity.

In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.

Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.

The AHRQ, Mayo Clinic, AMA, and National Academy of Medicine each recommend actions steps for all organizational levels to help build more supportive environments.

Women with prior HC-associated depression had a higher risk of developing a depressive episode during pregnancy and postpartum than women with non-HC-associated depression.

Your daily dose of clinical news you may have missed.

Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.

Your daily dose of clinical news you may have missed.

Four months of meditation improved quality of life and psychological symptoms in patients with CAD, according to research presented at ESC Preventive Cardiology 2023.

AUD affects 15 million Americans, with men nearly 2 times more vulnerable to the disease vs women. Are you tracking signs and symptoms in your patients?

About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.

Rebekah Bernard, MD, family physician and national speaker on physician wellness shares 3 pieces of advice on connecting with colleagues again.

Yale Food Addiction Scale author Ashley Gearhardt, PhD, and National Poll on Healthy Aging director Jeffrey Kullgren, MD, MS, MPH, highlight new survey findings.

Primary care is increasingly the setting for mental health discussions, diagnosis, and treatment, underscoring the need for both structural and process change.

Your daily dose of clinical news you may have missed.

Carmen Kosicek, MSN, PMHNP-BC; Charles Montano, MD; and Gus Alva, MD, DFAPA, provide take-home messages for the management of patients with MDD and other depressive disorders.

Experts in psychiatry examine emerging agents and unmet needs for the management of MDD.

Reductions in depressive symptoms were greater in adolescents aged ≥13 years and in those with a mental illness and/or depression diagnosis, according to systematic review and meta-analysis.